For Fast Release:


Today, the U.S. Food items and Drug Administration approved the very first COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty (koe-mir’-na-tee), for the avoidance of COVID-19 sickness in people today 16 decades of age and more mature. The vaccine also carries on to be available underneath emergency use authorization (EUA), together with for men and women 12 via 15 several years of age and for the administration of a 3rd dose in selected immunocompromised people.

“The FDA’s approval of this vaccine is a milestone as we continue to struggle the COVID-19 pandemic. Though this and other vaccines have satisfied the FDA’s demanding, scientific requirements for emergency use authorization, as the 1st Fda-accredited COVID-19 vaccine, the general public can be very self-assured that this vaccine meets the superior expectations for security, performance, and producing quality the Fda requires of an accepted products,” reported Performing Food and drug administration Commissioner Janet Woodcock, M.D. “While hundreds of thousands of people have by now safely received COVID-19 vaccines, we identify that for some, the Food and drug administration acceptance of a vaccine may well now instill more assurance to get vaccinated. Today’s milestone puts us one particular action nearer to altering the study course of this pandemic in the U.S.” 

Given that Dec. 11, 2020, the Pfizer-BioNTech COVID-19 Vaccine has been available underneath EUA in people today 16 decades of age and more mature, and the authorization was expanded to include things like those 12 via 15 several years of age on May possibly 10, 2021. EUAs can be made use of by the Food and drug administration throughout public well being emergencies to give entry to professional medical merchandise that may perhaps be powerful in protecting against, diagnosing, or treating a ailment, provided that the Food and drug administration decides that the recognized and potential benefits of a item, when utilised to protect against, diagnose, or treat the condition, outweigh the known and prospective challenges of the solution.

Food and drug administration-permitted vaccines endure the agency’s standard approach for reviewing the high quality, protection and usefulness of healthcare products. For all vaccines, the Fda evaluates details and information and facts involved in the manufacturer’s submission of a biologics license application (BLA). A BLA is a extensive document that is submitted to the agency supplying pretty particular necessities. For Comirnaty, the BLA builds on the substantial details and facts previously submitted that supported the EUA, these as preclinical and clinical data and facts, as very well as aspects of the producing approach, vaccine testing effects to make sure vaccine high-quality, and inspections of the web-sites in which the vaccine is built. The agency conducts its very own analyses of the info in the BLA to make sure the vaccine is safe and powerful and fulfills the FDA’s expectations for acceptance. 

Comirnaty incorporates messenger RNA (mRNA), a sort of genetic material. The mRNA is used by the overall body to make a mimic of one particular of the proteins in the virus that triggers COVID-19. The outcome of a particular person acquiring this vaccine is that their immune technique will finally respond defensively to the virus that will cause COVID-19. The mRNA in Comirnaty is only existing in the entire body for a shorter time and is not included into – nor does it change – an individual’s genetic materials. Comirnaty has the exact same formulation as the EUA vaccine and is administered as a collection of two doses, a few months aside. 

“Our scientific and clinical professionals carried out an amazingly thorough and considerate evaluation of this vaccine. We evaluated scientific details and details included in hundreds of countless numbers of pages, conducted our individual analyses of Comirnaty’s safety and usefulness, and executed a thorough evaluation of the manufacturing procedures, which include inspections of the manufacturing services,” said Peter Marks, M.D., Ph.D., director of FDA’s Middle for Biologics Evaluation and Study. “We have not missing sight that the COVID-19 community health disaster carries on in the U.S. and that the community is counting on safe and sound and helpful vaccines. The community and medical community can be self-confident that though we approved this vaccine expeditiously, it was entirely in preserving with our present high requirements for vaccines in the U.S.”

Fda Evaluation of Security and Effectiveness Facts for Acceptance for 16 Decades of Age and More mature

The very first EUA, issued Dec. 11, for the Pfizer-BioNTech COVID-19 Vaccine for people 16 a long time of age and more mature was dependent on protection and effectiveness info from a randomized, managed, blinded ongoing scientific trial of 1000’s of men and women. 

To help the FDA’s approval conclusion right now, the Fda reviewed current data from the clinical demo which supported the EUA and bundled a extended period of abide by-up in a much larger scientific demo populace. 

Specifically, in the FDA’s overview for approval, the company analyzed usefulness facts from somewhere around 20,000 vaccine and 20,000 placebo recipients ages 16 and older who did not have evidence of the COVID-19 virus infection inside of a week of getting the 2nd dose. The basic safety of Comirnaty was evaluated in close to 22,000 folks who obtained the vaccine and 22,000 individuals who gained a placebo 16 years of age and older.

Based mostly on benefits from the clinical trial, the vaccine was 91{b6f0c0f514f4e3fa2d7d033b2adb644b77328e2e54336d6fa71675349505545d} effective in preventing COVID-19 disease. 

Much more than 50 percent of the medical trial participants were adopted for safety outcomes for at the very least 4 months after the next dose. In general, around 12,000 recipients have been adopted for at least 6 months.

The most frequently reported side consequences by these clinical demo contributors who acquired Comirnaty were being ache, redness and inflammation at the injection website, fatigue, headache, muscle or joint discomfort, chills, and fever. The vaccine is powerful in blocking COVID-19 and probably serious outcomes including hospitalization and loss of life.

Moreover, the Food and drug administration executed a demanding evaluation of the write-up-authorization basic safety surveillance data pertaining to myocarditis and pericarditis adhering to administration of the Pfizer-BioNTech COVID-19 Vaccine and has determined that the knowledge reveal elevated challenges, notably in just the 7 days adhering to the second dose. The noticed risk is higher among males beneath 40 several years of age as opposed to girls and more mature males. The noticed hazard is best in males 12 by way of 17 many years of age. Out there details from small-phrase stick to-up counsel that most persons have experienced resolution of signs and symptoms. Having said that, some individuals required intensive care assistance. Facts is not still available about opportunity extensive-phrase health and fitness outcomes. The Comirnaty Prescribing Data involves a warning about these threats.

Ongoing Safety Monitoring

The Food and drug administration and Centers for Ailment Handle and Avoidance have checking techniques in location to guarantee that any protection considerations go on to be discovered and evaluated in a well timed way. In addition, the Food and drug administration is demanding the company to conduct postmarketing research to further more assess the dangers of myocarditis and pericarditis adhering to vaccination with Comirnaty. These scientific tests will contain an analysis of extended-expression outcomes among individuals who create myocarditis pursuing vaccination with Comirnaty. In addition, despite the fact that not Food and drug administration prerequisites, the corporation has dedicated to additional put up-internet marketing protection research, which include conducting a pregnancy registry examine to appraise being pregnant and toddler results soon after receipt of Comirnaty in the course of pregnancy.

The Food and drug administration granted this software Precedence Assessment. The approval was granted to BioNTech Manufacturing GmbH.

Related Facts



The Fda, an company inside the U.S. Office of Wellbeing and Human Expert services, guards the general public wellbeing by assuring the safety, success, and security of human and veterinary medicines, vaccines and other organic items for human use, and health-related products. The company also is liable for the safety and safety of our nation’s meals offer, cosmetics, dietary health supplements, products and solutions that give off digital radiation, and for regulating tobacco products and solutions.